Demographics, Treatment Patterns, Safety, and Real-World Effectiveness in Patients ≥70 Years of Age with Chronic Lymphocytic Leukemia Receiving Bendamustine with or without Rituximab

被引：0
|
作者：
Kolibaba, Kathryn S. [1 ]
Joshi, Avani D. [2 ]
Sterchele, James A. [3 ]
Forsyth, Michael [2 ]
Alwon, Erin [2 ]
Beygi, Hooman [3 ]
Kennealey, Gerard T. [3 ]
机构：
[1] NW Canc Specialists, Vancouver, WA USA
[2] US Oncol, The Woodlands, TX USA
[3] Cephalon Inc, Frazer, PA USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1674 / 1674
页数：1
相关论文
共 50 条
  • [1] Demographics, treatment patterns, safety, and real-world effectiveness in patients aged 70 years and over with chronic lymphocytic leukemia receiving bendamustine with or without rituximab: a retrospective study
    Kolibaba, Kathryn S.
    Sterchele, James A.
    Joshi, Avani D.
    Forsyth, Michael
    Alwon, Erin
    Beygi, Hooman
    Kennealey, Gerard T.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2013, 4 (03) : 157 - 171
  • [2] Real-World Efficacy and Safety of Bendamustine with or without Rituximab in Treatment-Naive Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of a German Registry
    Guenther, Georg
    Bartels, Stefan
    Tessen, Hans-Werner
    Sterchele, James A.
    BLOOD, 2012, 120 (21)
  • [3] Real-world treatment patterns and characteristics in patients with chronic lymphocytic leukemia
    Schenkel, Brad
    Rider, Alex
    Macomson, Brian
    Hallworth, Pam
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08)
  • [4] Real-World Effectiveness and Safety of Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL) in Belgium after 4 Years
    Saevels, Kirsten
    Snauwaert, Sylvia
    Vanstralen, Gaeten
    Andre, Marc
    Offner, Fritz
    Maes, Ariane
    Lahaye, Marjolein
    Janssens, Ann
    BLOOD, 2023, 142
  • [5] Real-World Effectiveness and Safety Outcomes of Acalabrutinib Treatment By Line of Therapy in Patients with Chronic Lymphocytic Leukemia and/or Small Lymphocytic Lymphoma
    Jacobs, Ryan W.
    Teschemaker, Anna
    Hakre, Shweta
    Tian, Hongping
    Pyrih, Nick
    Wahlstrom, Svea K.
    Cui, Lianzhou
    BLOOD, 2023, 142
  • [6] Real-World Patterns of MRD Testing and Impact on Treatment for Chronic Lymphocytic Leukemia Patients
    Bacchus, Melissa
    Singh-Bulkan, Nivita
    Littleford, Hana E.
    Kim, Joseph
    Martin, Richard L.
    Lacoste, Alix M. B.
    Brimble, Elise
    O'Brien, Conner
    Saltzman, Larry A.
    Greenberger, Lee M.
    Nottke, Amanda
    BLOOD, 2023, 142
  • [7] Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study
    Muta, Tsuyoshi
    Masamoto, Yosuke
    Yamamoto, Go
    Kurahashi, Shingo
    Kameoka, Yoshihiro
    Ota, Shuichi
    Matsuki, Eri
    Ozeki, Kazutaka
    Toyama, Takanori
    Takahashi, Naoki
    Kumode, Takahiro
    Aotsuka, Nobuyuki
    Yoshimura, Takuro
    Tamura, Hideto
    Omi, Ai
    Shibayama, Kazuhiro
    Watanabe, Aki
    Isobe, Yasushi
    Kojima, Kensuke
    Takizawa, Jun
    Nagai, Hirokazu
    Suzumiya, Junji
    Aoki, Sadao
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, : 161 - 173
  • [8] BTK Inhibitor Ibrutinib/Zanubrutinib Plus Bendamustine and Rituximab As the Initial Treatment for Chronic Lymphocytic Leukemia/ Small Lymphocytic Leukemia : a Single Arm Real-World Study
    Zhu, Huayuan
    Wu, Wei
    Sha, Yeqin
    Jin, Ze
    Yang, Yilian
    Qiu, Jingyan
    Ding, Chongyang
    Wang, Zhen
    Shi, Chuanbing
    Peng, Chen
    Mi, Hongling
    Chen, Ruize
    Wang, Li
    Fan, Lei
    Xu, Wei
    Li, Jianyong
    BLOOD, 2021, 138
  • [9] Venetoclax Effectiveness, Safety, and Treatment Patterns in Chronic Lymphocytic Leukemia Patients: Results from the CLL Collaborative Study of Real-World Evidence (CORE)
    Zheng, Dandan
    Sail, Kavita
    Roeker, Lindsey E.
    Manzoor, Beenish S.
    Tuncer, Hande H.
    Allan, John N.
    Ujjani, Chaitra S.
    Barr, Paul M.
    Brown, Jennifer R.
    Eyre, Toby A.
    Skarbnik, Alan
    Bannerji, Rajat
    Eichhorst, Barbara
    Brander, Danielle M.
    Sharmokh, Simon
    Jiang, Daniel Dingfeng
    Pena, German
    Kamalakar, Rajesh
    Emechebe, Nnadozie
    Pivneva, Irina
    Burne, Rebecca
    Guerin, Annie
    Davids, Matthew S.
    Mato, Anthony
    BLOOD, 2020, 136
  • [10] Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia
    Roeker, Lindsey E.
    DerSarkissian, Maral
    Ryan, Kellie
    Chen, Yan
    Duh, Mei Sheng
    Wahlstrom, Svea K.
    Hakre, Shweta
    Yu, Louise
    Guo, Helen
    Mato, Anthony R.
    BLOOD ADVANCES, 2023, 7 (16) : 4291 - 4301
12345